logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/06/2025
Bitcoin fell by over 0.4%, approaching $103,000.
Latest
3 m ago
Shenzhen Energy and Huawei collaborate on developing a new energy meteorological power forecasting large model.
9 m ago
When asked about the news of the rumored sale of Maserati, a spokesperson for Stellantis said, "Forgive me for being blunt, but Maserati is not for sale."
14 m ago
Micron Technology (MU.US) announces upcoming financial results and receives target price upgrade from Wedbush.
14 m ago
On June 21, according to the Novo Nordisk website, Novo Nordisk announced the results of the Phase 3b STEPUP trial for non-diabetic obese patients at the American Diabetes Association (ADA) scientific meeting in Chicago. The data showed that during the 72-week treatment period, higher doses of Wegovy (semaglutide 7.2mg) led to an average weight loss of 21% in obese patients compared to placebo, with one-third of participants achieving a weight loss of 25% or more. The safety and tolerability of the higher dose of Wegovy (7.2mg) was consistent with the 2.4mg dose.
19 m ago
The new augmented reality program can assist users in independently completing professional tasks.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.